ALEMBIC PHARMACEUTICALS LTD.
|
Market Cap.(`)
|
16262.65 Cr.
|
P/BV
|
3.33
|
Book Value (`)
|
248.68
|
|
52 Week High/Low ( ` )
|
1304/725
|
FV/ML
|
2/1
|
P/E(X)
|
26.41
|
|
Book Closure
|
15/07/2024
|
EPS (`)
|
31.33
|
Div Yield (%)
|
1.33
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 6112.11 | 5499.77 | 5231.79 | 5276.22 | 4491.97 |
| Other Operating Revenues | 116.51 | 152.85 | 74.00 | 116.91 | 113.78 |
| Total Operating Revenues | 6228.62 | 5652.62 | 5305.79 | 5393.13 | 4605.75 |
| | | | | | |
| Other Income | 28.31 | 2.74 | 50.46 | 10.02 | 4.94 |
| Total Revenue | 6256.93 | 5655.36 | 5356.25 | 5403.15 | 4610.69 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1403.01 | 1250.08 | 1129.11 | 1185.35 | 979.05 |
| Purchase Of Stock-In Trade | 454.91 | 380.09 | 360.50 | 265.92 | 270.93 |
| Operating And Direct Expenses | 0.00 | 50.90 | 0.00 | 22.39 | 17.56 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -142.84 | 78.65 | -43.19 | -193.93 | -210.59 |
| Employee Benefit Expenses | 1446.29 | 1169.13 | 1133.00 | 1051.17 | 906.44 |
| Finance Costs | 56.19 | 50.17 | 17.73 | 16.02 | 27.16 |
| Depreciation And Amortisation Expenses | 272.67 | 275.43 | 286.78 | 183.47 | 157.32 |
| Other Expenses | 2133.90 | 2015.39 | 1852.21 | 1504.68 | 1419.34 |
| Total Expenses | 5624.13 | 5269.84 | 4736.14 | 4035.07 | 3567.21 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 632.80 | 385.52 | 620.11 | 1368.08 | 1043.48 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -43.65 |
| Profit/Loss Before Tax | 632.80 | 385.52 | 620.11 | 1368.08 | 999.83 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 65.81 | 4.20 | 129.18 | 255.47 | 204.57 |
| Deferred Tax | -46.06 | 9.20 | -23.47 | -9.56 | -4.30 |
| Tax For Earlier Years | -3.75 | -0.79 | -1.25 | 7.41 | -1.09 |
| Total Tax Expenses | 16.00 | 12.61 | 104.46 | 253.32 | 199.18 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 616.80 | 372.91 | 515.65 | 1114.76 | 800.65 |
| | | | | | |
| Profit/Loss From Continuing Operations | 616.80 | 372.91 | 515.65 | 1114.76 | 800.65 |
| | | | | | |
| Profit/Loss For The Period | 616.80 | 372.91 | 515.65 | 1114.76 | 800.65 |
| | | | | | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 31.61 | 28.12 |
| Share Of Profit/Loss Of Associates | -0.98 | -30.92 | 5.29 | 31.74 | 0.05 |
| Consolidated Profit/Loss After MI And Associates | 615.82 | 341.99 | 520.94 | 1178.11 | 828.82 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 31.33 | 17.40 | 26.50 | 60.81 | 43.97 |
| Diluted EPS (Rs.) | 31.33 | 17.40 | 26.50 | 60.81 | 43.97 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 157.25 | 196.56 | 275.19 | 0.00 | 325.97 |